BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 19467459)

  • 1. [Quantitative dynamic MRI and localisation of non-palpable prostate cancer].
    Cornud F; Beuvon F; Thévenin F; Chauveinc L; Vieillefond A; Descazeaux A; Flam T
    Prog Urol; 2009 Jun; 19(6):401-13. PubMed ID: 19467459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
    Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Description of magnetic resonance imaging-derived enhancement variables in pathologically confirmed prostate cancer and normal peripheral zone regions.
    Zelhof B; Lowry M; Rodrigues G; Kraus S; Turnbull L
    BJU Int; 2009 Sep; 104(5):621-7. PubMed ID: 19281464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
    Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA
    J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast enhanced MRI of the prostate: comparison of gadobutrol and Gd-DTPA.
    Durmus T; Vollnberg B; Schwenke C; Kilic E; Huppertz A; Taupitz M; Franiel T
    Rofo; 2013 Sep; 185(9):862-8. PubMed ID: 23888476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
    Franiel T; Lüdemann L; Rudolph B; Rehbein H; Staack A; Taupitz M; Prochnow D; Beyersdorff D
    Invest Radiol; 2008 Jul; 43(7):481-7. PubMed ID: 18580330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
    Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
    Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer.
    van Dorsten FA; van der Graaf M; Engelbrecht MR; van Leenders GJ; Verhofstad A; Rijpkema M; de la Rosette JJ; Barentsz JO; Heerschap A
    J Magn Reson Imaging; 2004 Aug; 20(2):279-87. PubMed ID: 15269954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
    Tanimoto A; Nakashima J; Kohno H; Shinmoto H; Kuribayashi S
    J Magn Reson Imaging; 2007 Jan; 25(1):146-52. PubMed ID: 17139633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T.
    Li C; Chen M; Li S; Zhao X; Zhang C; Luo X; Zhou C
    Acta Radiol; 2014 Mar; 55(2):239-47. PubMed ID: 23892233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens.
    Puech P; Potiron E; Lemaitre L; Leroy X; Haber GP; Crouzet S; Kamoi K; Villers A
    Urology; 2009 Nov; 74(5):1094-9. PubMed ID: 19773038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
    Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis--correlation with biopsy and histopathology.
    Kozlowski P; Chang SD; Jones EC; Berean KW; Chen H; Goldenberg SL
    J Magn Reson Imaging; 2006 Jul; 24(1):108-13. PubMed ID: 16767709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
    Gemeinhardt O; Lüdemann L; Prochnow D; Abramjuk C; Taupitz M; Hamm B; Beyersdorff D
    Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.
    Kim JK; Hong SS; Choi YJ; Park SH; Ahn H; Kim CS; Cho KS
    J Magn Reson Imaging; 2005 Nov; 22(5):639-46. PubMed ID: 16200542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer.
    Delongchamps NB; Beuvon F; Eiss D; Flam T; Muradyan N; Zerbib M; Peyromaure M; Cornud F
    Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):232-7. PubMed ID: 21423266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings.
    Villers A; Puech P; Mouton D; Leroy X; Ballereau C; Lemaitre L
    J Urol; 2006 Dec; 176(6 Pt 1):2432-7. PubMed ID: 17085122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Principal component analysis of dynamic contrast enhanced MRI in human prostate cancer.
    Eyal E; Bloch BN; Rofsky NM; Furman-Haran E; Genega EM; Lenkinski RE; Degani H
    Invest Radiol; 2010 Apr; 45(4):174-81. PubMed ID: 20177391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps.
    Sung YS; Kwon HJ; Park BW; Cho G; Lee CK; Cho KS; Kim JK
    AJR Am J Roentgenol; 2011 Nov; 197(5):1122-9. PubMed ID: 22021504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.